- Report
- December 2023
- 80 Pages
Russia
From €1422EUR$1,500USD£1,188GBP
- Report
- December 2023
- 80 Pages
Japan
From €1422EUR$1,500USD£1,188GBP
- Report
- December 2023
- 80 Pages
Ireland
From €1422EUR$1,500USD£1,188GBP
- Report
- December 2023
- 80 Pages
Brazil
From €1422EUR$1,500USD£1,188GBP
- Report
- April 2025
- 50 Pages
Global
From €2512EUR$2,650USD£2,098GBP
Artemether is an antimalarial drug used to treat and prevent malaria caused by Plasmodium falciparum. It is a semi-synthetic derivative of the natural product artemisinin, and is used in combination with other antimalarial drugs. Artemether is also used to treat other infectious diseases, such as schistosomiasis, filariasis, and leishmaniasis. It is available in both oral and injectable forms, and is generally well tolerated with few side effects.
Artemether is an important drug in the treatment of infectious diseases, as it is effective against a wide range of parasites. It is also relatively inexpensive, making it an attractive option for those in developing countries. Artemether is widely available in many countries, and is often used in combination with other antimalarial drugs.
Several companies are involved in the production and distribution of artemether. These include Cipla, Novartis, Sanofi, and GlaxoSmithKline. Other companies, such as Ranbaxy, Lupin, and Sun Pharmaceuticals, also produce and distribute artemether. Show Less Read more